{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":5,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":5,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"ef6dc853d087","filters":{"venue":"Precision Cancer Medicine"}},"results":[{"id":"W3159637394","doi":"10.21037/pcm-20-69","title":"A narrative review of chemotherapy in advanced triple negative breast cancer","year":2021,"lang":"en","type":"review","venue":"Precision Cancer Medicine","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Eribulin; Medicine; Oncology; Internal medicine; Triple-negative breast cancer; Breast cancer; Anthracycline; Taxane; Olaparib; Gemcitabine; Chemotherapy; Capecitabine; Metastatic breast cancer; Cancer; Colorectal cancer","authors":[{"name":"María Luisa Romero Lagunes","is_ca":true},{"name":"Rossanna C. Pezo","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05870134318040379,"gpt":0.4804741947722393,"spread":0.4217728515918355,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001167189,0.000845666,0.00152809,0.004480766,0.0004726602,0.001960546,0.0008071728,0.001423643,0.007139693],"category_scores_gemma":[0.007025294,0.0003622995,0.001242713,0.00447526,0.0005098318,0.0018,0.0009146341,0.001290097,0.001173759],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001486665,"about_ca_system_score_gemma":0.003239507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002506124,"about_ca_topic_score_gemma":0.004177316,"domain_scores_codex":[0.9988173,0.0004227163,0.0003902227,0.0001195717,0.0002044707,0.00004583746],"domain_scores_gemma":[0.9946406,0.003996707,0.000753144,0.00005727268,0.0004741151,0.00007810827],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001823085,0.00005183765,0.0004686071,0.3550782,0.0004175986,0.0009016849,0.0007433652,0.0003645,0.0004952085,0.005594928,0.09542999,0.5402719],"study_design_scores_gemma":[0.00002979689,0.0001150005,0.001305864,0.2375681,0.0008955532,0.003246431,0.0003287734,0.00008002691,0.0001371652,0.001187732,0.7550771,0.00002833105],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001202181,0.9979074,0.00005966601,0.0005961866,0.0003187367,0.00002261483,0.00008542182,0.00000321326,0.0008865322],"genre_scores_gemma":[0.001188406,0.9970752,0.0001786175,0.0007375682,0.0004159546,0.0000424077,0.00009678518,0.000002466596,0.0002626079],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007139693,"threshold_uncertainty_score":0.02388459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3144883130","doi":"10.21037/pcm-20-58","title":"The role of immunotherapy in metastatic triple negative breast cancer: a narrative review of the current clinical trials","year":2021,"lang":"en","type":"review","venue":"Precision Cancer Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Alberta Cancer Foundation","funders":"","keywords":"Triple-negative breast cancer; Immunotherapy; Metastatic breast cancer; Oncology; Medicine; Clinical trial; Breast cancer; Narrative; Narrative review; Internal medicine; Cancer; Cancer immunotherapy; Intensive care medicine; Art","authors":[{"name":"Kim Koczka","is_ca":true},{"name":"Nancy Nixon","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1618161013579067,"gpt":0.5293993507710599,"spread":0.3675832494131532,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002504767,0.0008604131,0.002678567,0.002065263,0.0003295254,0.001760063,0.001374305,0.001325834,0.004565622],"category_scores_gemma":[0.004634628,0.0003395822,0.002212403,0.002196764,0.0004692001,0.001861058,0.000830223,0.001984433,0.0007784764],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007783099,"about_ca_system_score_gemma":0.001945127,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006749443,"about_ca_topic_score_gemma":0.001694656,"domain_scores_codex":[0.9992181,0.0002374787,0.0002197002,0.00008958401,0.0001827284,0.00005248683],"domain_scores_gemma":[0.9966574,0.002281019,0.000431353,0.00005335184,0.0004643007,0.000112494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005992881,0.0001153172,0.0003211851,0.1420732,0.0006899403,0.0001489877,0.0001299111,0.0004121706,0.0007261754,0.002213681,0.026167,0.8264032],"study_design_scores_gemma":[0.0004554134,0.001079745,0.002463512,0.2071403,0.005303347,0.001640917,0.0002442083,0.0003899535,0.0005638502,0.003106432,0.7775404,0.00007199732],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001172143,0.9989906,0.00005228266,0.0003562221,0.0001202358,0.00001876548,0.00003246366,0.000003536291,0.0003085823],"genre_scores_gemma":[0.0009164777,0.9979684,0.0001681107,0.0005580996,0.0001792313,0.00003612502,0.0000567045,0.000002170091,0.0001147205],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004565622,"threshold_uncertainty_score":0.01527357,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4319454669","doi":"10.21037/pcm-22-39","title":"The role of concurrent amplification of PD-L1, PD-L2 and JAK2 in metastatic lung adenocarcinoma as a biomarker of immune checkpoint inhibitor response: a case report","year":2023,"lang":"en","type":"article","venue":"Precision Cancer Medicine","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"PD-L1; Biomarker; Adenocarcinoma; Cancer research; Immune checkpoint; Immune system; Immunotherapy; Lung cancer; Medicine; Oncology; Immunology; Cancer; Internal medicine; Biology; Genetics","authors":[{"name":"William J. Phillips","is_ca":true},{"name":"Arif Awan","is_ca":true},{"name":"Bernard Lo","is_ca":true},{"name":"A. Redway","is_ca":false},{"name":"Garth Nicholas","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03174351883292337,"gpt":0.3968917742011644,"spread":0.365148255368241,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006932723,0.002060481,0.001679316,0.003755829,0.003334424,0.002981624,0.001746063,0.007870497,0.002167849],"category_scores_gemma":[0.004104663,0.001811517,0.001830559,0.00172001,0.002351905,0.003131022,0.002206231,0.004747621,0.001121067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00218171,"about_ca_system_score_gemma":0.0009988957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003465428,"about_ca_topic_score_gemma":0.004098834,"domain_scores_codex":[0.9987612,0.0001702247,0.0001569355,0.0003640756,0.0002116237,0.0003360589],"domain_scores_gemma":[0.9970224,0.0009725577,0.0005906555,0.0002804387,0.0002148356,0.0009189814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.00002402249,0.00001675076,0.003205349,0.00002736668,0.000007480543,0.9951323,0.0001355437,0.00005800652,0.0005302451,0.00008526863,0.0001531532,0.0006244886],"study_design_scores_gemma":[0.000004265021,0.00002814079,0.001306209,0.00001053599,0.0000119671,0.9976788,0.00008617366,0.0002485872,0.0002876899,0.00008246465,0.0002481795,0.000007069026],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9700787,0.008878329,0.004992184,0.005671941,0.0003637616,0.0002599669,0.0003818281,0.00025282,0.00912054],"genre_scores_gemma":[0.993952,0.00156074,0.00210542,0.0007343455,0.0007862982,0.00002514475,0.00008492418,0.00003160404,0.0007194428],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007870497,"threshold_uncertainty_score":0.0158295,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4285050759","doi":"10.21037/pcm-22-21","title":"Introduction to Management of Triple Negative Breast Cancer","year":2022,"lang":"en","type":"article","venue":"Precision Cancer Medicine","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Triple-negative breast cancer; Cancer; Breast cancer; Medicine; Oncology; Internal medicine","authors":[{"name":"Jacques Raphael","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01129126158190201,"gpt":0.3013720399521503,"spread":0.2900807783702483,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001491,0.0007589372,0.0007116578,0.0007136916,0.0004676963,0.001233487,0.0008791278,0.00201519,0.01323413],"category_scores_gemma":[0.00340973,0.0003013662,0.0007466581,0.0004771684,0.0007196578,0.001117796,0.001202274,0.004083345,0.003906916],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008330374,"about_ca_system_score_gemma":0.001143588,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001177051,"about_ca_topic_score_gemma":0.001482725,"domain_scores_codex":[0.9993813,0.000254382,0.00006596793,0.0001117017,0.0001437704,0.00004274213],"domain_scores_gemma":[0.9983387,0.000898404,0.0001466238,0.00007255182,0.0003424253,0.0002013302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004091827,0.0002727736,0.001934258,0.003195789,0.0001107757,0.0006846012,0.0001525836,0.0003414539,0.002130313,0.01304817,0.2504849,0.7272353],"study_design_scores_gemma":[0.0001182977,0.0004672671,0.005287437,0.003823889,0.00008636923,0.002592969,0.00008365502,0.0001718281,0.0006718201,0.01247844,0.9741726,0.00004556754],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004129359,0.6533288,0.02340081,0.2482309,0.0279367,0.0004154836,0.001455553,0.0005853997,0.04051685],"genre_scores_gemma":[0.03249779,0.6649112,0.03560308,0.1636627,0.06479721,0.0008637602,0.001255564,0.0002219649,0.03618686],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01323413,"threshold_uncertainty_score":0.0442726,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3145138207","doi":"10.21037/pcm-20-64","title":"A narrative review of immune checkpoint inhibitors in early stage triple negative breast cancer","year":2021,"lang":"en","type":"review","venue":"Precision Cancer Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Immunotherapy; Oncology; Taxane; Triple-negative breast cancer; Pembrolizumab; Breast cancer; Atezolizumab; Internal medicine; Chemotherapy; Immune checkpoint; Population; Cancer","authors":[{"name":"Ana-Alicia Beltran-Bless","is_ca":true},{"name":"Terry L. Ng","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04721812796156658,"gpt":0.3967856712577745,"spread":0.3495675432962079,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008199934,0.0008186873,0.001736028,0.003720892,0.0003606029,0.001351504,0.0009870849,0.001227692,0.008526285],"category_scores_gemma":[0.003014142,0.0003399445,0.00130412,0.003208015,0.0003584647,0.001774689,0.0007902582,0.001723575,0.00167262],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009521228,"about_ca_system_score_gemma":0.001893602,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001397287,"about_ca_topic_score_gemma":0.00287381,"domain_scores_codex":[0.9995667,0.00009437839,0.0001476404,0.00006734018,0.00009793707,0.00002592133],"domain_scores_gemma":[0.998305,0.0009980925,0.0003296897,0.00002394913,0.0002638284,0.00007952222],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001704862,0.00005129739,0.0003511606,0.1311052,0.0002645155,0.0005723486,0.0001581065,0.0003639107,0.0005847046,0.00273451,0.1275344,0.7361094],"study_design_scores_gemma":[0.000040762,0.0001312745,0.001201497,0.06354859,0.000532303,0.003450223,0.0001012401,0.0001089248,0.0001481969,0.001071022,0.9296328,0.00003312141],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008604919,0.9978741,0.00006756357,0.000636853,0.0005713065,0.000014993,0.00006532133,0.000005046512,0.0006787995],"genre_scores_gemma":[0.0005824493,0.9971342,0.0001502467,0.0006958161,0.0008562235,0.00002636665,0.0001117705,0.000002377769,0.0004404839],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008526285,"threshold_uncertainty_score":0.02852333,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}